First up, let’s take a look at our HTNI Awards finalists in the category of innovation of the year.
Augmedix
Overview: California-based Audmedix, a provider of ambient Ai medical documentation and data services, announced general availability for its solution Augmedix Go following a successful pilot programme with HCA Healthcare.
Why? Augmedix Go aims to improve patient experience at the point of care, along with increasing productivity by improving documentation quality, reducing the burden of note-taking, and shortening chart closure time.
What happened? The solution enables clinicians to engage with patients in a hands-free environment by pairing the mobile app with a bluetooth mic, designed to seamlessly capture patient conversations. Large language models are then utilised across different specialties and sections of the clinical note in order to deliver “high quality medical documentation”. The solution has become generally available for emergency departments, with CEO Manny Krakaris stating that it enables clinicians “to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background”.
Artificial Heart Frontiers Program
Overview: The Artificial Heart Frontiers Program described as a “multidisciplinary consortium” led by Monash University in Melbourne, Australia, and aims to apply technology to transform heart failure care – particularly to “revolutionise” implantable heart devices in Australia.
Why? The team highlights a need for innovation in the clinical care of heart failure patients in Australia and globally. Australia sees 500,000 people affected by heart failure with 50,000 new diagnoses annually.
What happened? The program focuses on creating and developing the next generation of medical devices designed to address heart failure. In particularly, the program is working on the development and commercialisation of the BiVAVOR Total Artificial Heart: a device with an implantable rotatory blood pump utilising magnetic levitation technology as a “complete replacement” for the human heart. With few moving parts, the device has expectations of 10+ years in terms of durability; can be fitted in smaller adults and children due to its compact size; and offers a heart replacement device, rather than a temporary solution until a transplant becomes available. The program plans to work with BiVACOR to commercialise the device and manufacture parts in Australia.
Cross Country Healthcare
Overview: Cross Country Healthcare, a provider of workforce solutions, customised its flagship platform Intellify to suit client needs. Intellify is a talent management platform supported by business intelligence and provides increased workforce visibility and transparency through use of AI and data analytics.
Why? Cross Country identified a need to streamline talent acquisition and overcome challenges around integration with legacy systems.
What happened? Seeking to “achieve excellence”, Cross Country customised Intellify for clients with the provision of ad-hoc reporting and real-time dashboards which allowed leaders to make swift workforce decisions as well as improving staffing and patient care. The platform is currently deployed in 50 facilities with 500 users, and streamlines recruitment for 10,600 assignments nationwide. Looking to the future, Cross Country aims to achieve ongoing success through continuous training, updates and feedback mechanisms.
